watch
Takeda Pharmaceutical Co., Ltd.

Takeda Pharmaceutical Co., Ltd.

Sector: Pharmaceutical Preparations Region: Japan


: | Tokyo Stock Exchange: 4502 | OTC Markets: TKPYY | Frankfurt Stock Exchange: TKD | OTC Markets: TKPHF


Similar to: Cephalon, Inc., Bohai Pharmaceuticals Group, Inc., BioAlliance Pharma SA

Takeda Pharmaceutical Co., Ltd. is a research-based global pharmaceutical company engaged in the manufacture, import, export, and marketing of pharmaceutical drugs. Its operations are carried out through the following segments: Ethical Drugs Business, Consumer Healthcare Business, and Other Business. Ethical Drugs Business segment provides the manufacture and sale of pharmaceutical products. The Consumer Healthcare Business segment provides the manufacture and sale of healthcare drugs and quasi-drugs. The Other Business segment provides the manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded on June 12, 1781 and is headquartered in Osaka, Japan.

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

JCI's Conversation with Giants in Medicine: Tadataka "Tachi" Yamada

Giants in Medicine. Born in Japan and trained in the United States as a gastroenterologist, he quickly rose to be the chairman of the Department of Internal Medicine at University of Michigan. He moved to industry and eventually became the Chairman of Research and Development for GlaxoSmithKline. In the next step in his interesting career, he took on the presidency of the Bill and Melinda Gates Foundation Global Health Program. In this capacity, he oversaw over $9,000,000,000 in programs directed at addressing health challenges of the developing world. In 2011, Dr. Yamada moved on to become the Chief Medical and Scientific Officer (CMSO) and Executive Vice President of Takeda Pharmaceuticals.

Takeda Pharmaceutical Co., Ltd. video

JCI's Conversation with Giants in Medicine: Tadataka "Tachi" Yamada

Takeda Pharmaceutical Co., Ltd. video

Davos 2012 Co-Chair - Yasuchika Hasegawa

Takeda Pharmaceutical Co., Ltd. video

Takeda to Buy Nycomed for $9.1 Billion to Fill Sales Gap

Executives

Yasuchika Hasegawa, President and Chief Executive Officer
Professional Career 2011 Chairman, KEIZAI DOYUKAI (Japan Association of Corporate Executives) (to present) 2009 President & CEO of the Company (to present) 2003 President and Representative Director of the Company 2002 General Manager of Corporate Strategy & Planning Department of the Company 2001 General Manager of Corporate Planning Department of the Company 1999 Director of the Company 1998 Corporate Officer and General Manager of Pharmaceutical International Division of the Company 1970 Joined the Company
Frank Morich, M.D., PhD, Chief Commercial Officer
Professional Career 2011 Chief Commercial Officer (to present) 2011 Chief Executive Officer, Takeda Pharmaceuticals International GmbH (to present) 2011 Director of the Company (to present) 2010 Executive Vice President of Takeda Pharmaceuticals International Inc. (to present) 2010 Executive Vice President, International Operations (Americas/Europe) of the Company 2009 Member of the Takeda Global Advisory Board 2008 CEO, NOXXON Pharma AG 2005 CEO and Member of the Board of Directors, Innogenetics NV 2004 Chairman of Scientific Advisory Board, Forbion Capital Partners 2004 CEO, AM-Pharma B.V. 2002 Chairman of the Board of Management, Bayer HealthCare AG 2000 Member of the Board of Management, Bayer AG 1998 General Manager of Bayer AG
Tadataka Yamada, M.D., Chief Medical & Scientific Officer
Professional Career 2011 Chief Medical & Scientific Officer (to present) 2011 Executive Vice President of Takeda Pharmaceuticals International Inc. (to present) 2011 Medical and Scientific Advisor to the CEO of the Company 2011 Director of the Company (to present) 2011 Chairman, Management and Operations Committee 3 of the Company (to present) 2011 Member of the Board of Directors, Agilent Technologies, Inc. (to present) 2009 Member of the Takeda Global Advisory Board (to present) 2007 Member of the Board of Directors, Covidien plc 2006-2011President, Global Health Program, Bill and Melinda Gates Foundation 2004 Member of the Board of Directors, GlaxoSmithKline 2000 Chairman, R&D, GlaxoSmithKline

News & Analysis

You may also be interested in: